$VCEL
Vericel Corp

2019 Q2 Form 10-Q Financial Statement

#000162828019010077 Filed on August 06, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $26.15M $19.01M
YoY Change 37.56% 12.14%
Cost Of Revenue $9.022M $7.730M
YoY Change 16.71% 0.78%
Gross Profit $17.13M $11.28M
YoY Change 51.8% 21.56%
Gross Profit Margin 65.5% 59.36%
Selling, General & Admin $16.26M $11.79M
YoY Change 37.89% 33.49%
% of Gross Profit 94.92% 104.49%
Research & Development $21.07M $3.739M
YoY Change 463.52% 25.85%
% of Gross Profit 123.01% 33.14%
Depreciation & Amortization $400.0K $380.0K
YoY Change 5.26% 2.7%
% of Gross Profit 2.34% 3.37%
Operating Expenses $37.33M $15.53M
YoY Change 140.37% 31.57%
Operating Profit -$20.20M -$4.246M
YoY Change 375.74% 68.43%
Interest Expense $2.000K $448.0K
YoY Change -99.55% 49.83%
% of Operating Profit
Other Income/Expense, Net $408.0K -$405.0K
YoY Change -200.74% -404.51%
Pretax Income -$19.79M -$4.650M
YoY Change 325.59% 94.56%
Income Tax
% Of Pretax Income
Net Earnings -$19.79M -$4.651M
YoY Change 325.54% 94.77%
Net Earnings / Revenue -75.68% -24.46%
Basic Earnings Per Share -$0.45 -$0.12
Diluted Earnings Per Share -$0.45 -$0.12
COMMON SHARES
Basic Shares Outstanding 43.91M shares 36.68M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $66.00M $95.00M
YoY Change -30.53% 578.57%
Cash & Equivalents $14.00M $94.97M
Short-Term Investments $52.00M
Other Short-Term Assets $2.167M $1.327M
YoY Change 63.3% 18.91%
Inventory $4.788M $3.725M
Prepaid Expenses
Receivables $21.08M $17.50M
Other Receivables $0.00 $0.00
Total Short-Term Assets $94.05M $117.5M
YoY Change -19.97% 255.68%
LONG-TERM ASSETS
Property, Plant & Equipment $6.963M $4.673M
YoY Change 49.0% 33.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $31.78M $4.673M
YoY Change 580.03% 33.78%
TOTAL ASSETS
Total Short-Term Assets $94.05M $117.5M
Total Long-Term Assets $31.78M $4.673M
Total Assets $125.8M $122.2M
YoY Change 2.97% 234.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.250M $5.011M
YoY Change 4.77% -20.11%
Accrued Expenses $7.300M $5.100M
YoY Change 43.14% 765.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $2.800M
YoY Change -100.0% 33.33%
Total Short-Term Liabilities $12.54M $15.22M
YoY Change -17.59% 17.59%
LONG-TERM LIABILITIES
Long-Term Debt $100.0K $14.42M
YoY Change -99.31% 79.3%
Other Long-Term Liabilities $24.60M $2.000M
YoY Change 1130.0% 18081.82%
Total Long-Term Liabilities $24.70M $14.42M
YoY Change 71.34% 79.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.54M $15.22M
Total Long-Term Liabilities $24.70M $14.42M
Total Liabilities $37.28M $31.60M
YoY Change 18.01% 40.04%
SHAREHOLDERS EQUITY
Retained Earnings -$391.7M -$373.2M
YoY Change 4.96% 4.9%
Common Stock $480.1M $463.5M
YoY Change 3.57% 25.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $88.54M $90.60M
YoY Change
Total Liabilities & Shareholders Equity $125.8M $122.2M
YoY Change 2.97% 234.46%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$19.79M -$4.651M
YoY Change 325.54% 94.77%
Depreciation, Depletion And Amortization $400.0K $380.0K
YoY Change 5.26% 2.7%
Cash From Operating Activities -$18.38M -$5.450M
YoY Change 237.25% -3.71%
INVESTING ACTIVITIES
Capital Expenditures -$990.0K -$800.0K
YoY Change 23.75% 300.0%
Acquisitions
YoY Change
Other Investing Activities -$2.810M
YoY Change
Cash From Investing Activities -$3.810M -$800.0K
YoY Change 376.25% 300.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.070M 71.43M
YoY Change -98.5% 142760.0%
NET CHANGE
Cash From Operating Activities -18.38M -5.450M
Cash From Investing Activities -3.810M -800.0K
Cash From Financing Activities 1.070M 71.43M
Net Change In Cash -21.12M 65.18M
YoY Change -132.4% -1221.86%
FREE CASH FLOW
Cash From Operating Activities -$18.38M -$5.450M
Capital Expenditures -$990.0K -$800.0K
Free Cash Flow -$17.39M -$4.650M
YoY Change 273.98% -14.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0000887359
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
514000 USD
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
748000 USD
us-gaap Capital Leases Income Statement Interest Expense
CapitalLeasesIncomeStatementInterestExpense
2600000 USD
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43578000 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44066000 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43578000 shares
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44066000 shares
us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000 USD
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35280
dei Entity Registrant Name
EntityRegistrantName
VERICEL CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MI
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3096597
dei Entity Address Address Line1
EntityAddressAddressLine1
64 Sidney Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02139
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
556-0311
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
VCEL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44136896000 shares
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13962000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18286000 USD
CY2019Q2 us-gaap Short Term Investments
ShortTermInvestments
52047000 USD
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
64638000 USD
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21084000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23454000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
4788000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
3558000 USD
CY2019Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2167000 USD
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2847000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
94048000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
112783000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6963000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5906000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24815000 USD
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2019Q2 us-gaap Assets
Assets
125826000 USD
CY2018Q4 us-gaap Assets
Assets
118689000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5250000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7108000 USD
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4701000 USD
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6930000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2558000 USD
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2019Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
34000 USD
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
754000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12543000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14792000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24607000 USD
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2019Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
134000 USD
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1666000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
37284000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
16458000 USD
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
480050000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
471180000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
38000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-39000 USD
CY2019Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
104000 USD
CY2018Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
104000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-391650000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-369014000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
88542000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
102231000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
125826000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118689000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
17129000 USD
CY2018Q2 us-gaap Gross Profit
GrossProfit
11284000 USD
us-gaap Gross Profit
GrossProfit
30299000 USD
us-gaap Gross Profit
GrossProfit
21645000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21070000 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3739000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24078000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7468000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16259000 USD
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11791000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29779000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22745000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
37329000 USD
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
15530000 USD
us-gaap Operating Expenses
OperatingExpenses
53857000 USD
us-gaap Operating Expenses
OperatingExpenses
30213000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-20200000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4246000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-23558000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8568000 USD
CY2019Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2018Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
37000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2944000 USD
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
428000 USD
CY2018Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
83000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
908000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
83000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
2000 USD
CY2018Q2 us-gaap Interest Expense
InterestExpense
448000 USD
us-gaap Interest Expense
InterestExpense
4000 USD
us-gaap Interest Expense
InterestExpense
880000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18000 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
408000 USD
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-405000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
922000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3742000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-19792000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-4651000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22636000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12310000 USD
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.52
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43956000 shares
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38349000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43841000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37251000 shares
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-19792000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-4651000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22636000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12310000 USD
CY2019Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
35000 USD
CY2018Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
38000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19757000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4651000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22598000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12310000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
102231000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-2844000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2628000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
780000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
218000 USD
CY2019Q1 us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
42000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
103055000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-19792000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4183000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
850000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
211000 USD
CY2019Q2 us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
35000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
88542000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
22540000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-7659000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1348000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
851000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
127000 USD
CY2018Q1 astm Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
1727000 USD
CY2018Q1 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
-2001000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
20935000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-4651000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2465000 USD
CY2018Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
70090000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
964000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
148000 USD
CY2018Q2 astm Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
238000 USD
CY2018Q2 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
-409000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
90598000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22636000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12310000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
698000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
813000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6810000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3807000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2944000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-23000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-13000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-49000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
408000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1139000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1230000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-68000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-2370000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-771000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-680000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-254000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2238000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1049000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2229000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-462000 USD
astm Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-1007000 USD
astm Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
0 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
187000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-56000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18225000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5036000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
32402000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
45477000 USD
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1224000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
979000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11851000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-979000 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
70090000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2059000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2096000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1965000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-9000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-29000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2050000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
74122000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4324000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
68107000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18286000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26862000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13962000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94969000 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization </span></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vericel Corporation, a Michigan corporation (together with its consolidated subsidiaries referred to herein as the Company, Vericel, we, us or our), was incorporated in March 1989 and began employee-based operations in 1991. On May 30, 2014, Vericel completed the acquisition of certain assets and assumed certain liabilities of Sanofi, a French </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">société anonyme</span><span style="font-family:inherit;font-size:10pt;"> (Sanofi), including all of the outstanding equity interests of Genzyme Biosurgery ApS (Genzyme Denmark or the Danish subsidiary) (now known as Vericel Denmark ApS), a wholly-owned subsidiary of Sanofi, and a portfolio of patents and patent applications of Sanofi and certain of its subsidiaries for purposes of acquiring the portion of the cell therapy and regenerative medicine business related to the MACI</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;">, Epicel</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> and Carticel</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> products. The Company is a fully integrated, commercial-stage biopharmaceutical company and currently markets MACI and Epicel in the U.S. and holds exclusive rights to commercialize NexoBrid</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">® </sup></span><span style="font-family:inherit;font-size:10pt;">in all countries of North America. The Company is a leader in advanced cell therapies for the sports medicine and severe burn care markets. </span></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. At the end of the second quarter of 2017, the Company removed Carticel</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></span><span style="font-family:inherit;font-size:10pt;">(autologous cultured chondrocytes), an earlier generation autologous chrondocyte implant (ACI) product, from the market. The Company also markets Epicel</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></span><span style="font-family:inherit;font-size:10pt;">(cultured epidermal autografts), a permanent skin replacement Humanitarian Use Device (HUD) for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns greater than or equal to 30 percent of total body surface area (TBSA). The Company also entered into exclusive license and supply agreements with MediWound Ltd. (MediWound) to commercialize NexoBrid</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">® </sup></span><span style="font-family:inherit;font-size:10pt;">in all countries in North America. NexoBrid is a topically-administered biological product that enzymatically removes nonviable burn tissue, or eschar, in patients with deep partial and full-thickness thermal burns. NexoBrid is currently in clinical development in North America, and a U.S. Biologics License Application (BLA) currently is targeted for submission to the U.S. Food and Drug Administration (FDA) in the second quarter of 2020. The Company operates its business primarily in the U.S. in </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> reportable segment — the research, product development, manufacture and distribution of advanced therapies for use in the treatment of specific diseases.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#222222;">The accompanying condensed consolidated financial statements have been prepared on a basis, which assumes that the Company will continue as a going concern and contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business.  As of </span><span style="font-family:inherit;font-size:10pt;color:#222222;">June 30, 2019</span><span style="font-family:inherit;font-size:10pt;color:#222222;">, the Company has an accumulated deficit of </span><span style="font-family:inherit;font-size:10pt;color:#222222;"><span>$391.7 million</span></span><span style="font-family:inherit;font-size:10pt;color:#222222;"> and had a net loss of </span><span style="font-family:inherit;font-size:10pt;color:#222222;"><span>$19.8 million</span></span><span style="font-family:inherit;font-size:10pt;color:#222222;"> and </span><span style="font-family:inherit;font-size:10pt;color:#222222;"><span>$22.6 million</span></span><span style="font-family:inherit;font-size:10pt;color:#222222;"> during the </span><span style="font-family:inherit;font-size:10pt;color:#222222;">three and six</span><span style="font-family:inherit;font-size:10pt;color:#222222;"> months ended </span><span style="font-family:inherit;font-size:10pt;color:#222222;">June 30, 2019</span><span style="font-family:inherit;font-size:10pt;color:#222222;">.  The Company had cash and cash equivalents of </span><span style="font-family:inherit;font-size:10pt;color:#222222;"><span>$14.0 million</span></span><span style="font-family:inherit;font-size:10pt;color:#222222;">, and short-term investments of </span><span style="font-family:inherit;font-size:10pt;color:#222222;"><span>$52.0 million</span></span><span style="font-family:inherit;font-size:10pt;color:#222222;"> as of </span><span style="font-family:inherit;font-size:10pt;color:#222222;">June 30, 2019</span><span style="font-family:inherit;font-size:10pt;color:#222222;">.  The Company expects that existing cash, cash equivalents and short-term investments will be sufficient to support the Company's </span><span style="font-family:inherit;font-size:10pt;">current operations through at least 12 months from the issuance of these financial statements.</span><span style="font-family:inherit;font-size:10pt;color:#222222;"> The Company may seek additional funding through debt or equity financings.  However, the Company may not be able to obtain financing on acceptable terms or at all. The terms of any financing may adversely affect the holdings or the rights of the Company's shareholders.</span></div>
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14000000.0 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-391700000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-19800000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22600000 USD
CY2019Q2 us-gaap Short Term Investments
ShortTermInvestments
52000000.0 USD
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The condensed consolidated financial statements included herein have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC).  The preparation of condensed consolidated financial statements in conformity with generally accepted accounting principles in the United States of America (U.S. GAAP) requires management to make estimates, judgments, and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such rules and regulations. The financial statements reflect, in the opinion of management, all adjustments (consisting only of normal, recurring adjustments) necessary to state fairly the financial position and results of operations as of and for the periods indicated.  The results of operations for the </span><span style="font-family:inherit;font-size:10pt;">three and six</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">June 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, are not necessarily indicative of the results to be expected for the full year or for any other period. The </span><span style="font-family:inherit;font-size:10pt;">June 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> condensed consolidated balance sheet data was derived from the Company’s audited consolidated financial statements, but does not include all disclosures required by U.S. GAAP.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, as filed with the SEC on February 26, 2019 (Annual Report).</span></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Consolidated Statement of Cash Flows</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents certain supplementary cash flows information for the </span><span style="font-family:inherit;font-size:10pt;">six months ended</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">June 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:76%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended June 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Supplementary Cash Flows information:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Warrants exercised for common stock</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,409</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest paid (net of interest capitalized)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>754</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additions to equipment in process included in accounts payable</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>365</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>459</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Right-of-use asset and lease liability recognized</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>560</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div>
astm Warrants Exercised For Common Stock
WarrantsExercisedForCommonStock
0 USD
astm Warrants Exercised For Common Stock
WarrantsExercisedForCommonStock
2409000 USD
us-gaap Interest Paid Net
InterestPaidNet
4000 USD
us-gaap Interest Paid Net
InterestPaidNet
754000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
365000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
459000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
560000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26151000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19011000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47961000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37038000 USD
CY2019Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
4127000 USD
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2872000 USD
CY2019Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
596000 USD
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
638000 USD
CY2019Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
65000 USD
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
48000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
4788000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
3558000 USD
CY2019Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
166000 USD
CY2018Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0 USD
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15164000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13411000 USD
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8201000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7505000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6963000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5906000 USD
CY2019Q2 astm Depreciation Depletionand Amortization Excluding Intangible Assets
DepreciationDepletionandAmortizationExcludingIntangibleAssets
400000 USD
astm Depreciation Depletionand Amortization Excluding Intangible Assets
DepreciationDepletionandAmortizationExcludingIntangibleAssets
700000 USD
CY2018Q2 astm Depreciation Depletionand Amortization Excluding Intangible Assets
DepreciationDepletionandAmortizationExcludingIntangibleAssets
400000 USD
astm Depreciation Depletionand Amortization Excluding Intangible Assets
DepreciationDepletionandAmortizationExcludingIntangibleAssets
800000 USD
CY2019Q2 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
1528000 USD
CY2018Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
5161000 USD
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2695000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1559000 USD
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
478000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
210000 USD
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4701000 USD
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6930000 USD
CY2019Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000 USD
CY2019Q1 astm Right Of Use Asset
RightOfUseAsset
25600000 USD
CY2019Q1 astm Lease Liability
LeaseLiability
27800000 USD
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1300000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
2600000 USD
CY2019Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
100000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24815000 USD
CY2019Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
166000 USD
CY2019Q2 astm Right Of Use Asset
RightOfUseAsset
24981000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2558000 USD
CY2019Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
34000 USD
CY2019Q2 astm Lease Liability Current
LeaseLiabilityCurrent
2592000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24607000 USD
CY2019Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
134000 USD
CY2019Q2 astm Lease Liability Noncurrent
LeaseLiabilityNoncurrent
24741000 USD
astm Measurement Of Lease Liability
MeasurementOfLeaseLiability
2500000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2504000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
21000 USD
CY2019Q2 astm Lease Liability Payments Due Remainder Of Fiscal Year
LeaseLiabilityPaymentsDueRemainderOfFiscalYear
2525000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4944000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
41000 USD
CY2019Q2 astm Lease Liability Payments Due Year Two
LeaseLiabilityPaymentsDueYearTwo
4985000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4864000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
41000 USD
CY2019Q2 astm Lease Liability Payments Due Year Three
LeaseLiabilityPaymentsDueYearThree
4905000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4929000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
41000 USD
CY2019Q2 astm Lease Liability Payments Due Year Four
LeaseLiabilityPaymentsDueYearFour
4970000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4901000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
41000 USD
CY2019Q2 astm Lease Liability Payments Due Year Five
LeaseLiabilityPaymentsDueYearFive
4942000 USD
CY2019Q2 astm Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
4968000 USD
CY2019Q2 astm Finance Lease Liability Payments Due Year Six
FinanceLeaseLiabilityPaymentsDueYearSix
0 USD
CY2019Q2 astm Lease Liability Payments Due Year Six
LeaseLiabilityPaymentsDueYearSix
4968000 USD
CY2019Q2 astm Lessee Operating Lease Liability Payments Dueafter Year Six
LesseeOperatingLeaseLiabilityPaymentsDueafterYearSix
11269000 USD
CY2019Q2 astm Finance Lease Liability Payments Dueafter Year Six
FinanceLeaseLiabilityPaymentsDueafterYearSix
0 USD
CY2019Q2 astm Lease Liability Payments Due After Year Six
LeaseLiabilityPaymentsDueAfterYearSix
11269000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
38379000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
185000 USD
CY2019Q2 astm Lease Liability Payments Due
LeaseLiabilityPaymentsDue
38564000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11214000 USD
CY2019Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
17000 USD
CY2019Q2 astm Lease Liability Undiscounted Excess Amount
LeaseLiabilityUndiscountedExcessAmount
11231000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
27165000 USD
CY2019Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
168000 USD
CY2019Q2 astm Lease Liability
LeaseLiability
27333000 USD
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y3M3D
CY2019Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P4Y3D
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0953
CY2019Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0500
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
15386000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
4879000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
4719000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
4754000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
966000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
68000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
205000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
41000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
41000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
41000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
41000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
41000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2018Q4 astm Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due
OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDue
15591000 USD
CY2018Q4 astm Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due Current
OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueCurrent
4920000 USD
CY2018Q4 astm Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due In Two Years
OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueInTwoYears
4760000 USD
CY2018Q4 astm Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due In Three Years
OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueInThreeYears
4795000 USD
CY2018Q4 astm Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due In Four Years
OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueInFourYears
1007000 USD
CY2018Q4 astm Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Duein Five Years
OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueinFiveYears
109000 USD
CY2018Q4 astm Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due Thereafter
OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueThereafter
0 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4183000 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2465000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6810000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3807000 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
56840000 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
38000 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
56878000 USD
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
56878000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
75515000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
39000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
75476000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
75476000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-19792000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-4651000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22636000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12310000 USD
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43956000 shares
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38349000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43841000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37251000 shares
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.52
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2019Q2 us-gaap Incentive From Lessor
IncentiveFromLessor
2000000.0 USD
CY2019Q2 us-gaap Deferred Rent Credit
DeferredRentCredit
1900000 USD

Files In Submission

Name View Source Status
0001628280-19-010077-index-headers.html Edgar Link pending
0001628280-19-010077-index.html Edgar Link pending
0001628280-19-010077.txt Edgar Link pending
0001628280-19-010077-xbrl.zip Edgar Link pending
astm-20190630.xsd Edgar Link pending
astm-20190630_cal.xml Edgar Link unprocessable
astm-20190630_def.xml Edgar Link unprocessable
astm-20190630_lab.xml Edgar Link unprocessable
astm-20190630_pre.xml Edgar Link unprocessable
ex101-6thamendmenttodi.htm Edgar Link pending
ex1010-mediwoundsupply.htm Edgar Link pending
ex1011amendedandrestat.htm Edgar Link pending
ex1012-1stamendmenttom.htm Edgar Link pending
ex102-1stamendmenttodi.htm Edgar Link pending
ex109-mediwoundlicense.htm Edgar Link pending
ex311-ceocertification.htm Edgar Link pending
ex312-cfocertification.htm Edgar Link pending
ex321-ceosoxcertificat.htm Edgar Link pending
ex322-cfosoxcertificat.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
publiccopyredactedver_image1.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vericel6301910q.htm Edgar Link pending
vericel6301910q_htm.xml Edgar Link completed
vericellogoa18.jpg Edgar Link pending